Document Detail

Multicenter Experience on Eversion Versus Conventional Carotid Endarterectomy in Symptomatic Carotid Artery Stenosis: Observations From the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE-1) Trial.
MedLine Citation:
PMID:  22496334     Owner:  NLM     Status:  Publisher    
BACKGROUND AND PURPOSE: Carotid endarterectomy (CEA) is beneficial in patients with symptomatic carotid artery stenosis. However, randomized trials have not provided evidence concerning the optimal CEA technique, conventional or eversion. METHODS: The outcome of 563 patients within the surgical randomization arm of the Stent-Protected Angioplasty versus Carotid Endarterectomy in Symptomatic Patients (SPACE-1) trial was analyzed by surgical technique subgroups: eversion endarterectomy versus conventional endarterectomy with patch angioplasty. The primary end point was ipsilateral stroke or death within 30 days after surgery. Secondary outcome events included perioperative adverse events and the 2-year risk of restenosis, stroke, and death. RESULTS: Both groups were similar in terms of demographic and other baseline clinical variables. Shunt frequency was higher in the conventional CEA group (65% versus 17%; P<0.0001). The risk of ipsilateral stroke or death within 30 days after surgery was significantly greater with eversion CEA (9% versus 3%; P=0.005). There were no statistically significant differences in the rate of perioperative secondary outcome events with the exception of a significantly higher risk of intraoperative ipsilateral stroke rate in the eversion CEA group (4% versus 0.3%; P=0.0035). The 2-year risk of ipsilateral stroke occurring after 30 days was significantly higher in the conventional CEA group (2.9% versus 0%; P=0.017). CONCLUSIONS: In patients with symptomatic carotid artery stenosis, conventional CEA appears to be associated with better periprocedural neurological outcome than eversion CEA. Eversion CEA, however, may be more effective for long-term prevention of ipsilateral stroke. These findings should be interpreted with caution noting the limitations of the post hoc, nonrandomized nature of the analysis.
Serdar Demirel; Nicolas Attigah; Hans Bruijnen; Peter Ringleb; Hans-Henning Eckstein; Gustav Fraedrich; Dittmar Böckler;
Related Documents :
23647644 - Results of the wirk prospective, non-interventional observational study of recombinant ...
17947934 - Cardiac surgery in nonagenarians.
23047994 - Sequential right then left acute dacryoadenitis in crohn's disease.
19114904 - Interactive video instruction improves the quality of dispatcher-assisted chest compres...
18303254 - Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients w...
12028684 - Long-term clinical outcome of transurethral microwave thermotherapy (tumt) 1991-1999 at...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-10
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  -     ISSN:  1524-4628     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
From the Departments of Vascular Surgery and Neurology, University Hospital of Ruprecht-Karls, Heidelberg, Germany; the Department of Vascular Surgery, Augsburg City Hospital, University of Ludwig-Maximillians, Munich, Germany; the Department of Vascular Surgery, University Hospital of the Technical University of Munich, Munich, Germany; and the Department of Vascular Surgery, University Hospital of Innsbruck, Innsbruck, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnosis-related deterioration of lung function after extracorporeal membrane oxygenation.
Next Document:  Role of the MMP9 Gene in Hemorrhagic Transformations After Tissue-Type Plasminogen Activator Treatme...